申请人:EPIZYME, INC.
公开号:US20160024017A1
公开(公告)日:2016-01-28
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.
本文描述了公式(I)的化合物,其药学上可接受的盐以及其药物组合物。本发明的化合物可用于抑制精氨酸甲基转移酶活性。还描述了使用这些化合物治疗精氨酸甲基转移酶介导的疾病的方法。